Abstract

14Dec 2017 DOES EVIDENCE SUPPORT PROSTHETIC OR SURGICAL REHABILITATION FOR PATIENTS WITH MAXILLARY DEFECT REGARDING THE QUALITY OF LIFE SYSTEMATIC REVIEW. Sharaf .M.Y , Ibrahim S. I , Eskander A.E and Shawky A F. Assistant Lecture, Department of prosthodontics , Faculty of Dentistry, University of Beni-Suef. Egypt . Professor,Department of prosthodontics, Faculty of oral and dental medicine, University of Cairo. Cairo ,Egypt. Professor,Department of prosthodontics ,Faculty of oral and dental medicine,University of Cairo.Cairo ,Egypt. Assistant professor, Department of prosthodontics , Faculty of Dentistry, University of Beni-Suef. Egypt .

Highlights

  • Caribbean database for articles published before September 2017 was performed by two independent reviewers

  • A manual search of articles published from January 2000 to September 2017 was conducted .Only English studies were included which evaluate the quality of life (QoL) in patients with head and neck cancers .Any confusion between the two independent reviewers was resolved by means of a moderated discussion between the reviewers

  • Surgical rehabilitation provide a better line of treatment in improving the QOL for patients with maxillary defects, On the other hand prosthetic has proved effectiveness in the immediate postsurgical times as temporary strategy, and it has represented a good alternative when the surgical obturation is compromised

Read more

Summary

Results

Five studies fulfilled the inclusion criteria for this study. Many parameters were used regarding evaluation of QOL as the EORTC Head and Neck 35 assessment , UW-QOL , OHIP–14 , VAS, OFS, MHI ,HAD,Body Satisfaction Scale,Oral symptom check list, Swallowing, Diet consist, Pain control,Postoertive complication and Speech. Two studies supported the surgical line of treatment for improving the QOL as compared to the prosthetic one ,another two studies showed a statistically insignificant improvement in the patients‘ QOL with the surgical line , while only one revealed insignificant difference in QoL with both lines of treatment

Conclusions
The Results
15 Class Ib 15 Class II 8 Class III
Mucosal melanoma 3 Osteosarcoma

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.